Market Research Reports and Industry Reports

Ra Pharmaceuticals Inc (RARX) - Financial and Strategic SWOT Analysis Review

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION
Ra Pharmaceuticals Inc (RARX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Ra Pharmaceuticals Inc (Ra Pharmaceuticals) is a clinical stage biopharmaceutical company that develops therapeutics for the treatment of diseases caused due to uncontrolled activation of the complement system. The company discovers and develops peptides and small molecules that target key components of the complement cascade. Its lead product candidate, RA101495 is a self-administered subcutaneous (SC) injection into the tissue under the skin for the treatment of paroxysmal nocturnal hemoglobinuria (PNH). Ra Pharmaceuticals pipeline also includes RA101495, an administered SC, to treat debilitating complement-mediated diseases such as refractory generalized myasthenia gravis (rMG), and lupus nephritis (LN). The companys pipeline products are based on its proprietary peptide chemistry platform. Ra Pharmaceuticals is headquartered on Cambridge, Massachusetts, the US.

Ra Pharmaceuticals Inc Key Recent Developments

Aug 09,2017: Ra Pharmaceuticals Reports Second Quarter 2017 Financial Results
May 11,2017: Ra Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Corporate Update
Mar 06,2017: Ra Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update
Nov 29,2016: Ra Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Corporate Update
Apr 06,2016: Ra Pharmaceuticals Appoints Chief Scientific Officer and Expands Board of Directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Ra Pharmaceuticals Inc - Key Facts 5
Ra Pharmaceuticals Inc - Key Employees 6
Ra Pharmaceuticals Inc - Key Employee Biographies 7
Ra Pharmaceuticals Inc - Major Products and Services 8
Ra Pharmaceuticals Inc - History 9
Ra Pharmaceuticals Inc - Company Statement 10
Ra Pharmaceuticals Inc - Locations And Subsidiaries 12
Head Office 12
Section 2 Company Analysis 13
Ra Pharmaceuticals Inc - Business Description 13
Ra Pharmaceuticals Inc - SWOT Analysis 14
SWOT Analysis - Overview 14
Ra Pharmaceuticals Inc - Strengths 14
Ra Pharmaceuticals Inc - Weaknesses 15
Ra Pharmaceuticals Inc - Opportunities 16
Ra Pharmaceuticals Inc - Threats 17
Ra Pharmaceuticals Inc - Key Competitors 18
Section 3 Company Financial Ratios 19
Financial Ratios - Capital Market Ratios 19
Financial Ratios - Annual Ratios 20
Performance Chart 22
Financial Performance 22
Financial Ratios - Interim Ratios 23
Financial Ratios - Ratio Charts 24
Section 4 Companys Lifesciences Financial Deals and Alliances 25
Ra Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 25
Ra Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 26
Ra Pharmaceuticals Inc, Recent Deals Summary 27
Section 5 Companys Recent Developments 28
Aug 09, 2017: Ra Pharmaceuticals Reports Second Quarter 2017 Financial Results 28
May 11, 2017: Ra Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Corporate Update 29
Mar 06, 2017: Ra Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update 30
Nov 29, 2016: Ra Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Corporate Update 32
Apr 06, 2016: Ra Pharmaceuticals Appoints Chief Scientific Officer and Expands Board of Directors 34
Jan 06, 2016: Ra Pharmaceuticals Strengthens Senior Management Team 35
Section 6 Appendix 36
Methodology 36
Ratio Definitions 36
About GlobalData 40
Contact Us 40
Disclaimer 40

List Of Tables


Ra Pharmaceuticals Inc, Key Facts 5
Ra Pharmaceuticals Inc, Key Employees 6
Ra Pharmaceuticals Inc, Key Employee Biographies 7
Ra Pharmaceuticals Inc, Major Products and Services 8
Ra Pharmaceuticals Inc, History 9
Ra Pharmaceuticals Inc, Key Competitors 18
Ra Pharmaceuticals Inc, Ratios based on current share price 19
Ra Pharmaceuticals Inc, Annual Ratios 20
Ra Pharmaceuticals Inc, Annual Ratios (Cont...1) 21
Ra Pharmaceuticals Inc, Interim Ratios 23
Ra Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 25
Ra Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 26
Ra Pharmaceuticals Inc, Recent Deals Summary 27
Currency Codes 36
Capital Market Ratios 36
Equity Ratios 37
Profitability Ratios 37
Cost Ratios 38
Liquidity Ratios 38
Leverage Ratios 39
Efficiency Ratios 39

List Of Figures


Ra Pharmaceuticals Inc, Performance Chart (2014 - 2016) 22
Ra Pharmaceuticals Inc, Ratio Charts 24
Ra Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 25
Ra Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 26

Global Commercial Vehicle Disc Brake Sales Market Report 2017

In this report, the global Commercial Vehicle Disc Brake market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of

USD 4000View Report

Global Cold Rolled Grain-Oriented Silicon Steel Sales Market Report 2017

In this report, the global Cold Rolled Grain-Oriented Silicon Steel market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end

USD 4000View Report

Global Chemotherapy Chairs Sales Market Report 2017

In this report, the global Chemotherapy Chairs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing

USD 4000View Report

Polaris Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Polaris Pharmaceuticals Inc (Polaris) is a biopharmaceutical company that conducts research and development of protein drugs for the treatment of cancer and other enervating diseases. The companys ADI-PEG 20, is

USD 250View Report

Oxeia Biopharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Oxeia Biopharmaceuticals Inc (Oxeia Biopharmaceuticals) develops therapies for the treatment of mild traumatic brain injury (MTBI) or concussions and underlying neuro-metabolic dysfunction. The companys lead pipeline candidate OXE-103 acts as

USD 250View Report

Milestone Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Milestone Pharmaceuticals Inc (Milestone Pharmaceuticals) specializes in cardiovascular drug development. The company undertakes the development of small molecule therapeutics based on clinically validated mechanisms, for the treatment of cardiovascular

USD 250View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
Country Code.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 125
  • Site Licence    USD 250
  • Enterprise Wide Licence    USD 375
$ 125

Reports Details

Published Date : Aug 2017
No. of Pages :40
Country :United States of America
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube
paykasa bozdurma,paykasa bozdurma,astropay bozdurma,paykasa,paykasa,paykasa bozdurma,paykasa,astropay bozdurma,justin kart,bitcoin bozdurma,paykasa bozum,paykasa kart bozdurma,
beylikduzu escort,bahçeşehir escort,escort istanbul,istanbul escort,sex hikayeleri,pendik escort,
pedalebiellese.com,
istanbul escort bayan,besiktas escort,maltepe escort,kadikoy escort bayan,tekirdag escort bayan,findikzade escort,antalya escort bayan,ankara escort bayan,
Böcek İlaçlama,şehirler arası nakliyat,şehirler arası evden eve nakliyat,ofis taşıma,gebze evden eve nakliyat,kadıköy evden eve nakliyat,istanbul evden eve nakliyat,epoksi zemin,
ankara escort,ankara escort,ankara escort,
tipobet,
seo teknikleri wordpress ücretsiz tema istanbul sexs shop hacklink e sigara sexs shop